Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Division of Ophthalmology, Department of Surgery, Lahey Hospital & Medical Center, Peabody, Massachusetts, USA.
Ophthalmic Physiol Opt. 2022 Sep;42(5):965-972. doi: 10.1111/opo.12998. Epub 2022 May 11.
This study describes the implementation of an electronic medical record (EMR)-based initiative aimed at identifying and reducing the number of patients with diabetic retinopathy (DR) lost to follow-up (LTF).
Providers were enlisted to review the EMRs and re-engage patients with DR seen 1 year prior and who had not returned for care within the past 6 months. Binary logistic regression analysis was used to identify demographic, clinical and sociomedical factors associated with being LTF, as well as those predictive of re-engagement.
Out of 673 patients with DR, 78 (12%) were identified as LTF. Patients LTF were more likely to be younger (p = 0.001) and have poorly controlled haemoglobin A1c (HbA1c ≥ 8%, p = 0.04) and cholesterol (LDL ≥ 100 mg/dL, p < 0.001) levels. These patients were also more likely to have completed fewer ophthalmology appointments (p < 0.001), and less likely to have had retinal imaging within the last year (p < 0.001). Charts reviewed 1 month after the EMR-based initiative revealed that 22 patients (28%) had been successfully re-engaged by providers, while 56 patients (72%) remained LTF. History of prior treatment for DR was associated with re-engagement by providers (p = 0.04). One month following the provider-based intervention, the LTF rate dropped to 8.3%, and by 1 year only 3.6% of the patients remained LTF.
Electronic medical record-based tools can successfully identify DR patients as being LTF, offering an opportunity for providers to re-engage patients in a timely manner. Future studies are needed to determine the long-term impact of patient re-engagement on DR outcomes and efficiency of clinical practice.
本研究描述了一项基于电子病历(EMR)的举措的实施情况,该举措旨在发现并减少糖尿病视网膜病变(DR)患者的失访(LTF)数量。
招募提供者审查 EMR 并重新接触 1 年前看过的 DR 患者,这些患者在过去 6 个月内未返回接受治疗。采用二元逻辑回归分析确定与 LTF 相关的人口统计学、临床和社会医学因素,以及预测重新参与的因素。
在 673 名 DR 患者中,有 78 名(12%)被确定为 LTF。LTF 的患者更年轻(p=0.001),且糖化血红蛋白(HbA1c≥8%,p=0.04)和胆固醇(LDL≥100mg/dL,p<0.001)水平控制较差。这些患者也更有可能完成较少的眼科预约(p<0.001),并且在过去一年中不太可能进行视网膜成像(p<0.001)。在基于 EMR 的计划实施后 1 个月,审查的图表显示 22 名患者(28%)已被提供者成功重新参与,而 56 名患者(72%)仍为 LTF。DR 先前治疗史与提供者的重新参与相关(p=0.04)。在提供者干预措施实施一个月后,LTF 率降至 8.3%,一年后仅 3.6%的患者仍为 LTF。
基于电子病历的工具可以成功识别出 LTF 的 DR 患者,为提供者及时重新接触患者提供了机会。需要进一步研究来确定患者重新参与对 DR 结果和临床实践效率的长期影响。